Search

Haya M Almalag,1 Lobna Al Juffali,1 Maha M Alshehri,2 Nouf A Altokhais,2 Ghada A Aljanobi,3 Maha I El Dessougi,4 Amal AlHarthi,4 Suzan M Attar,5 Sami M Bahlas,5 Abdullah S Alfurayj,6 Mansour S Alazmi,7 Alhussain M Asiri,8 Mohammed M AlOmair,8 Mohammed A Omair9 1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 3Rheumatology Unit, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; 4Rheumatology Unit, Department of Medicine, Security Forces Hospital, Riyadh, Saudi Arabia; 5Rheumatology Unit, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 6Rheumatology Unit, Department of Medicine, Buraidah Central Hospital, Buraidah, Saudi Arabia; 7Rheumatology Unit, Department of Medicine, Prince Mohammed Medical City, Sakaka-Aljouf, Saudi Arabia; 8Rheumatology Unit, Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia; 9Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Haya M Almalag, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, Email halmalaq@ksu.edu.saIntroduction: Multidisciplinary setting in healthcare provide positive patient outcomes.Objective: To evaluate the impact of specialized rheumatology clinics (multidisciplinary settings) on the activation and engagement of rheumatoid arthritis (RA) patients.Material and Methods: This cross-sectional survey assessed patient activation using the patient activation measure-13. Participants attending Specialized Rheumatology Clinics (SRC multidisciplinary clinics) were compared with age- and sex-matched patients attending Standard of Care (SOC). The study was observational in nature, assessing several demographic and therapeutic options and their relation to the clinical setting and patient activation.Results: This study included 117 SRC matched RA patient

Mohammed A Omair,1 Maha M Alshehri,2 Nouf A Altokhais,2 Ghada A Aljanobi,3 Maha I El Dessougi,4 Amal AlHarthi,4 Maha A Omair,5 Suzan M Attar,6 Sami M Bahlas,6 Abdullah S Alfurayj,7 Mansour S Alazmi,8 Alhussain M Asiri,9 Mohammed M AlOmair,9 Lobna Al Juffali,10 Haya M Almalag10 1Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia; 2College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 3Rheumatology Unit, Department of Medicine, Qatif Central Hospital, Qatif, Saudi Arabia; 4Rheumatology Unit, Department of Medicine, Security Forces Hospital, Riyadh, Saudi Arabia; 5Department of Statistics and Operations Research, College of Science, King Saud University, Riyadh, Saudi Arabia; 6Rheumatology Unit, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 7Rheumatology Unit, Department of Medicine, Buraidah Central Hospital, Buraidah, Saudi Arabia; 8Rheumatology Unit, Department of Medicine, Prince Mohammed Medical City, Sakaka-Aljouf, Saudi Arabia; 9Rheumatology Unit, Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia; 10Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Mohammed A Omair, Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia, Tel +966505270513, Email momair@ksu.edu.saPurpose: Compliance is essential to achieve treatment goals in rheumatoid arthritis (RA) patients. The current study evaluated compliance and related factors in a large and diverse population.Patients and Methods: Patients with RA who received active treatment were invited to participate in an online survey. The Arabic versions of the 5-Item Compliance Questionnaire for Rheumatology (ACQR-5) and the RA Impact of Disease (RAID) were used to measure compliance and disability, respectively. The patients were sub-grouped based on background disease-modifying anti-rheumatic drugs (DMARDs). Variables associated with high complianc

Mohammad Mustafa,1 Yasser Bawazir,2 Leena Merdad,3 Siraj Wali,4 Suzan Attar,2 Omar Fathaldin,2 Sami Bahlas,2 Faris Alhejaili,4 Ahmed Aljohaney,4 Ahmed Jan,5 Fatima Jadu51Rheumatology Unit, Department of Medicine, University of Jeddah, Jeddah, Makkah, Kingdom of Saudi Arabia; 2Rheumatology Unit, Department of Medicine, King Abdulaziz University, Jeddah, Makkah, Kingdom of Saudi Arabia; 3Community Medicine Department, King Abdulaziz University, Jeddah, Makkah, Kingdom of Saudi Arabia; 4Sleep Medicine and Research Center, King Abdulaziz University Hospital, Jeddah, Makkah, Kingdom of Saudi Arabia; 5Faculty of Dentistry, King Abdulaziz University, Jeddah, Makkah, Kingdom of Saudi ArabiaPurpose: To determine the prevalence of common sleep problems among patients with rheumatoid arthritis (RA) and their relationship with the disease activity and quality of life.Patients and methods: The study sample consisted of 101 patients who attended a rheumatology clinic at a university hospital between October 2015 and May 2016. All subjects were clinically examined and interviewed by physicians using a questionnaire. The collected information included sociodemographic characteristics, the patients’ medical histories, the Disease Activity Score (DAS28), the Berlin questionnaire to assess the risk of obstructive sleep apnea (OSA), the Epworth Sleepiness Scale to assess excessive daytime sleepiness (EDS), the Athens Insomnia Scale to assess insomnia, the International RLS Study Group score to diagnose restless legs syndrome (RLS), and the Health Assessment Questionnaire (HAQ) to assess the quality of life.Results: The mean age of the participants was 48.7±14.6 years, and 95% of the participants were females. Approximately 60% of the participants were in the remission/low category of disease activity, and the average DAS28 score was 3.3±0.8 years. The prevalence rates of insomnia, EDS, sleep disturbance, risk of OSA, and RLS were 63%, 20%, 20%, 37%, and

Aim: To show the validity and reliability of the translated Hill-Bone scale on 110 hypertensive participants from an Arabic speaking country. Background: With the wide spread availability of treatment, individuals with hypertension have reported various levels of adherence to their medications. Flexible and practical methods of measuring adherence are the use of surveys, scales and interviews. There is a scarcity in Arabic tools and scales that measure levels of adherence to antihypertensive treatments in the Arabic speaking context. Design and Methods: A cross-sectional study was conducted among 110 individuals diagnosed with hypertension and from an Arabic speaking country. The Hill-Bone scale includes three subscales that measure salt intake, medication adherence and appointment keeping. Given the focus on the pharmacological management of hypertensive patients, only items related to medication adherence and appointment keeping subscales were used. The scale was translated by following a comprehensive and accepted method of translation. Results: Instrument reliability was tested by identifying the Cronbach’s alpha coefficient. The subscale for medication adherence in the Hill-Bone scale reported an acceptable level of reliability (Cronbach’s alpha =0.76). Compared with other translated versions of the Hill-Bone scale, the scale also reported good reliability and validity. Conclusion: Results indicate that the Arabic translated version of the Hill-Bone scale has an acceptable level of reliability and validity and therefore can be used in Arabic speaking populations.